HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance.

Sinevici, Nicoleta; Ataeinia, Bahar; Zehnder, Veronica; Lin, Kevin; Grove, Lauren; Heidari, Pedram; Mahmood, Umar

Sinevici, Nicoleta; Ataeinia, Bahar; Zehnder, Veronica; Lin, Kevin; Grove, Lauren; Heidari, Pedram; Mahmood, Umar.

Afiliação

Sinevici N; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Ataeinia B; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Zehnder V; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Lin K; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Grove L; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Heidari P; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Mahmood U; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.

Front Oncol ; 10: 554704, 2020.

Article em En | MEDLINE | ID: mdl-33330026

Palavras-chave

microenvironment; neuregulin; resistance; triple negative breast cancer; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google